Mary Lee Vance

16.6k total citations · 2 hit papers
158 papers, 9.6k citations indexed

About

Mary Lee Vance is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, Mary Lee Vance has authored 158 papers receiving a total of 9.6k indexed citations (citations by other indexed papers that have themselves been cited), including 143 papers in Endocrinology, Diabetes and Metabolism, 59 papers in Surgery and 30 papers in Genetics. Recurrent topics in Mary Lee Vance's work include Pituitary Gland Disorders and Treatments (127 papers), Growth Hormone and Insulin-like Growth Factors (89 papers) and Adrenal and Paraganglionic Tumors (54 papers). Mary Lee Vance is often cited by papers focused on Pituitary Gland Disorders and Treatments (127 papers), Growth Hormone and Insulin-like Growth Factors (89 papers) and Adrenal and Paraganglionic Tumors (54 papers). Mary Lee Vance collaborates with scholars based in United States, Canada and Taiwan. Mary Lee Vance's co-authors include Edward R. Laws, Michael O. Thorner, Jason P. Sheehan, Mark E. Molitch, David R. Clemmons, George R. Merriam, Saúl Malozowski, Shereen Ezzat, William E. Dodge and William T. Couldwell and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Annals of Internal Medicine.

In The Last Decade

Mary Lee Vance

157 papers receiving 9.3k citations

Hit Papers

The prevalence of pituita... 2004 2026 2011 2018 2004 2011 250 500 750

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Mary Lee Vance 8.2k 3.2k 2.0k 1.9k 843 158 9.6k
Anne Klibanski 9.0k 1.1× 3.1k 1.0× 1.9k 0.9× 1.1k 0.6× 1.4k 1.7× 141 11.3k
Alberto M. Pereira 11.6k 1.4× 4.1k 1.3× 1.7k 0.8× 1.2k 0.6× 1.4k 1.7× 342 14.2k
Beverly M. K. Biller 11.3k 1.4× 4.1k 1.3× 1.2k 0.6× 899 0.5× 1.3k 1.5× 221 13.7k
Peter Trainer 7.7k 0.9× 3.0k 0.9× 1.2k 0.6× 497 0.3× 886 1.1× 205 9.5k
John P. Monson 6.9k 0.8× 2.2k 0.7× 1.1k 0.6× 522 0.3× 1.2k 1.4× 189 8.7k
Philippe Chanson 11.9k 1.4× 5.3k 1.7× 2.6k 1.3× 1.5k 0.8× 2.7k 3.2× 396 16.7k
John Newell‐Price 10.5k 1.3× 5.6k 1.7× 1.1k 0.6× 589 0.3× 880 1.0× 168 12.4k
Niki Karavitaki 5.8k 0.7× 2.7k 0.8× 1.2k 0.6× 1.5k 0.8× 583 0.7× 157 6.8k
Pia Burman 4.3k 0.5× 1.5k 0.5× 769 0.4× 702 0.4× 713 0.8× 99 5.5k
David L. Kleinberg 5.7k 0.7× 2.1k 0.7× 991 0.5× 433 0.2× 1.2k 1.4× 96 7.5k

Countries citing papers authored by Mary Lee Vance

Since Specialization
Citations

This map shows the geographic impact of Mary Lee Vance's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Lee Vance with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Lee Vance more than expected).

Fields of papers citing papers by Mary Lee Vance

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Lee Vance. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Lee Vance. The network helps show where Mary Lee Vance may publish in the future.

Co-authorship network of co-authors of Mary Lee Vance

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Lee Vance. A scholar is included among the top collaborators of Mary Lee Vance based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Lee Vance. Mary Lee Vance is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Taylor, Davis G., Dale Ding, Zhiyuan Xu, et al.. (2019). Whole Sella vs Targeted Stereotactic Radiosurgery for Acromegaly: A Multicenter Matched Cohort Study. Neurosurgery. 86(5). 656–664. 8 indexed citations
2.
Bunevičius, Adomas, et al.. (2019). Surgical and radiosurgical treatment strategies for Cushing’s disease. Journal of Neuro-Oncology. 145(3). 403–413. 13 indexed citations
3.
Ironside, Natasha, Ching‐Jen Chen, Cheng‐Chia Lee, et al.. (2018). Outcomes of Pituitary Radiation for Cushing’s Disease. Endocrinology and Metabolism Clinics of North America. 47(2). 349–365. 15 indexed citations
4.
Vance, Mary Lee, et al.. (2013). CASE 6—2013 Perioperative Management of an Adult Patient With Tetralogy of Fallot and Pheochromocytoma. Journal of Cardiothoracic and Vascular Anesthesia. 27(6). 1399–1406. 2 indexed citations
5.
Kim, Dongil, Ji-Young Son, & Mary Lee Vance. (2012). Preparing for the Future IT Era: Perceptions of Students with Disabilities about IT Training in South Korea.. The Journal of Postsecondary Education and Disability. 25(4). 297–308. 6 indexed citations
6.
Freda, Pamela U., Albert Beckers, Laurence Katznelson, et al.. (2011). Pituitary Incidentaloma: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism. 96(4). 894–904. 356 indexed citations
7.
Schlesinger, David, et al.. (2011). Long-term Outcomes After Gamma Knife Radiosurgery for Patients With a Nonfunctioning Pituitary Adenoma. Neurosurgery. 69(2). 284–293. 79 indexed citations
8.
Molitch, Mark E., David R. Clemmons, Saúl Malozowski, George R. Merriam, & Mary Lee Vance. (2011). Evaluation and Treatment of Adult Growth Hormone Deficiency: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism. 96(6). 1587–1609. 639 indexed citations breakdown →
9.
Longtine, Janina A., David Schiff, John A. Jane, et al.. (2010). Temozolomide Treatment for Aggressive Pituitary Tumors: Correlation of Clinical Outcome with O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation and Expression. The Journal of Clinical Endocrinology & Metabolism. 95(11). E280–E290. 108 indexed citations
10.
Vance, Mary Lee, et al.. (2009). Serving Wounded Warriors: Current Practices in Postsecondary Education.. The Journal of Postsecondary Education and Disability. 22(1). 18–35. 36 indexed citations
12.
Vance, Mary Lee. (2008). Pituitary Adenoma: A Clinician’S Perspective. Endocrine Practice. 14(6). 757–763. 12 indexed citations
13.
Vance, Mary Lee. (2008). Cushing’s disease: radiation therapy. Pituitary. 12(1). 11–14. 18 indexed citations
14.
Jagannathan, Jay, Jason P. Sheehan, Nader Pouratian, et al.. (2008). GAMMA KNIFE RADIOSURGERY FOR ACROMEGALY. Neurosurgery. 62(6). 1262–1270. 84 indexed citations
15.
Molitch, Mark E., David R. Clemmons, Saúl Malozowski, et al.. (2006). Evaluation and Treatment of Adult Growth Hormone Deficiency: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism. 91(5). 1621–1634. 269 indexed citations
16.
Kanter, Adam S., John A. Jane, Jason P. Sheehan, et al.. (2005). Single-center experience with pediatric Cushing's disease. Journal of Neurosurgery Pediatrics. 103(5). 413–420. 52 indexed citations
17.
Vance, Mary Lee. (2003). Perioperative management of patients undergoing pituitary surgery. Endocrinology and Metabolism Clinics of North America. 32(2). 355–365. 30 indexed citations
18.
Newman, Connie B., Шломо Мелмед, Ajax E. George, et al.. (1998). Octreotide as Primary Therapy for Acromegaly1. The Journal of Clinical Endocrinology & Metabolism. 83(9). 3034–3040. 14 indexed citations
19.
Laws, Edward R., Michael O. Thorner, & Mary Lee Vance. (1996). Bromocriptine therapy for prolactin-secreting pituitary adenomas. Neurosurgical FOCUS. 1(1). E7–E7. 3 indexed citations
20.
Baumann, Gerhard, Mary Lee Vance, MELISSA A. SHAW, & Michael O. Thorner. (1990). Plasma Transport of Human Growth HormoneIn Vivo*. The Journal of Clinical Endocrinology & Metabolism. 71(2). 470–473. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026